NASDAQ •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 05/05/2026 16:00
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization193.6 mln
Float11.25 mln
Earnings Date07/30/2026
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.95
Likely reliable
Relative Strength
34
/ 100
Underperforming
Debt / Equity
0.18
Very low leverage
ROE
-7.68
Negative
Dividend Yield
0.00%
No dividend
Business Description
Anika Therapeutics, founded in 1983 and based in Bedford, Massachusetts, develops products designed to protect joints and reduce the need for invasive procedures by addressing orthopedic conditions at an early stage. The company offers a range of treatments for osteoarthritis pain, including injection-based therapies and bone repair solutions, as well as products that support cartilage and tissue regeneration. Beyond orthopedics, Anika also markets treatments for surgical adhesion prevention, eye care, and joint health in horses. Its products are sold across the United States, Europe, and other international markets.
